• 7024 malaria professionals are enjoying the free benefits of MalariaWorld today

p.falciparum

Open Access | Malaria control in Bhutan: a case study of a country embarking on elimination

Author(s): 
Yangzom T, Smith Gueye C, Namgay R, Galappaththy GN, Thimasarn K, Gosling R, Murugasampillay S, Dev V
Reference: 
Malaria Journal 2012, 11:9 (9 January 2012)
Contact email: 
thinleyangzom@googlemail.com

MalariaWorldBhutan has made significant strides towards elimination and has adopted a goal of national elimination.

Cyclopropyl Carboxamides, a Chemically Novel Class of Antimalarial Agents Identified in a Phenotypic Screen

Author(s): 
Laura M. Sanz, M. Belen Jiménez-Díaz, Francisco-Javier Gamo, et al.
Reference: 
Antimicrob. Agents Chemother. December 2011 vol. 55 no. 12 5740-5745

MalariaWorldMalaria is one of the deadliest infectious diseases in the world, with the eukaryotic parasite Plasmodium falciparum causing the most severe form of the disease.

Open Access | Sexual recombination is a signature of a persisting malaria epidemic in Peru

Author(s): 
Sutton PL, Torres LP, Branch OH
Reference: 
Malaria Journal 2011, 10:329 (31 October 2011)
Contact email: 
patrick.sutton@nyu.edu

MalariaWorldContrary to conventional low transmission models, this study provides evidence of a parasite population structure that is superficially defined by a clonal backbone.

Open Access | Drug-Resistant Genotypes and Multi-Clonality in Plasmodium falciparum Analysed by Direct Genome Sequencing from Peripheral Blood of Malaria Patients

Author(s): 
Timothy Robinson, Susana G. Campino, Sarah Auburn, Samuel A. Assefa, Spencer D. Polley, Magnus Manske, Bronwyn MacInnis, Kirk A. Rockett, Gareth L. Maslen, Mandy Sanders, Michael A. Quail, Peter L. Chiodini, Dominic P. Kwiatkowski, Taane G. Clark, Colin J. Sutherland
Reference: 
PLoS ONE 6(8): e23204
Contact email: 
colin.sutherland@lshtm.ac.uk

Naturally acquired blood-stage infections of the malaria parasite Plasmodium falciparum typically harbour multiple haploid clones.

Open Access | Evidence for erythrocyte-binding antigen 175 as a component of a ligand-blocking blood-stage malaria vaccine

Author(s): 
Lubin Jiang, Deepak Gaur, Jianbing Mu, Hong Zhou, Carole A. Long, and Louis H. Miller
Reference: 
PNAS May 3, 2011 vol. 108 no. 18 7553-7558
Contact email: 
ljiang@niaid.nih.gov

The ligands that pathogens use to invade their target cells have often proven to be good targets for vaccine development.

Open Access | Targeted Disruption of py235ebp-1: Invasion of Erythrocytes by Plasmodium yoelii Using an Alternative Py235 Erythrocyte Binding Protein

Author(s): 
Solabomi A. Ogun, Rita Tewari, Thomas D. Otto, Steven A. Howell, Ellen Knuepfer, Deirdre A. Cunningham, Zhengyao Xu, Arnab Pain, Anthony A. Holder
Reference: 
PLoS Pathog 7(2): e1001288
Contact email: 
sogun@nimr.mrc.ac.uk

Plasmodium yoelii YM asexual blood stage parasites express multiple members of the py235 gene family, part of the super-family of genes including those coding for Plasmodium vivax reticulocyte binding proteins and Plasmodium falciparum RH proteins.

Open Access | Evaluation of prevalences of pfdhfr and pfdhps mutations in Angola

Author(s): 
Fortes F, Dimbu R, Figueiredo P, Neto Z, do Rosario VE, Lopes D
Reference: 
Malaria Journal 2011, 10:22 (2 February 2011)
Contact email: 
filomenofortes@gmail.com

The data showed that the implementation IPT using SP in children needs to be reviewed.

Randomized double-blind controlled Phase I/IIa trial to assess the efficacy of malaria vaccine PfCS102 to protect against challenge with P. falciparum

Author(s): 
Blaise G., Valérie D., et al.
Reference: 
Vaccine, Volume 28, Issue 40, 14 September 2010, Pages 6573-6580
Contact email: 
Blaise.genton@hospvd.ch

The aim of this Phase I/IIa double-blind controlled trial was to test the efficacy of the sporozoite-based malaria vaccine PfCS 282–383 (PfCS102) to protect against Plasmodium falciparum parasitaemia.

Synthesis, Structure-Activity Relationship, and Mode-of-Action Studies of Antimalarial Reversed Chloroquine Compounds

Author(s): 
SJ Burgess, JX Kelly, S Shomloo, S Wittlin, R Brun, K Liebmann, DH Peyton
Reference: 
J. Med. Chem. August 4, 2010
Contact email: 
peytond@pdx.edu

We have previously shown that a "reversed chloroquine (RCQ)" molecule, composed of a chloroquine-like moiety and a resistance reversal-like moiety, can overcome chloroquine resistance in P. falciparum

Characterization of coproporphyrinogen III oxidase in Plasmodium falciparum cytosol

Author(s): 
Viswanathan Arun Nagaraj, Dasari Prasad, Rajavel Arumugam, Pundi N. Rangarajan, Govindarajan Padmanaban
Reference: 
Parasitology International, Volume 59, Issue 2, June 2010, Pages 121-127
Contact email: 
geepee@biochem.iisc.ernet.in

In this study, a recombinant P. falciparum coproporphyrinogen III oxidase (rPfCPO) was produced in E. coli and confirmed to be active under aerobic conditions.

Syndicate content